vWFkoncentrátumok
vWFkoncentrátumok refer to therapeutic products derived from human plasma that contain high concentrations of von Willebrand factor (vWF). These concentrates are used to treat patients with von Willebrand disease (vWD), a bleeding disorder characterized by a deficiency or dysfunction of vWF. vWF plays a crucial role in hemostasis, promoting platelet aggregation and acting as a carrier protein for coagulation factor VIII.
Treatment with vWF concentrate aims to restore normal vWF levels in the blood, thereby improving the ability
There are different types of vWF concentrates available. Some contain both vWF and factor VIII (known as